Mehmet Zafer Goren

Mehmet Zafer Goren


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2009 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
EKEsra Küçükibrahimoğlu
Esra Küçükibrahimoğlu
MSMelek Z. Saygın
Melek Z. Saygın
MÇMecit Çalışkan
Mecit Çalışkan
OKOkan K. Kaplan
Okan K. Kaplan
CÜCüneyt Ünsal
Cüneyt Ünsal
MGM Zafer Gören
M Zafer Gören

9 June 2007 in CNS Drug Reviews
Verified
Journal Article
Closed access
PDF file
MGMehmet Zafer Goren
Mehmet Zafer Goren
FOFiliz Onat
Filiz Onat

8 May 2007 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
MGMehmet Zafer Goren
Mehmet Zafer Goren
EKEsra Küçükibrahimoglu
Esra Küçükibrahimoglu
KBKemal Berkman
Kemal Berkman
BTBerna Terzioglu
Berna Terzioglu

31 May 2020 in Clinical Psychopharmacology and Neuroscience
Verified
Journal Article
Open access
PDF file
DKDr. SEMA KETENCİ
Dr. SEMA KETENCİ
NANazife Gökçe Acet
Nazife Gökçe Acet
GSGökçe Elif Sarıdoğan
Gökçe Elif Sarıdoğan
BABanu Aydın
Banu Aydın
HCHülya Cabadak
Hülya Cabadak
MGMehmet Zafer Goren
Mehmet Zafer Goren
Sema Ketenci, Nazife Gökçe Acet, Gökçe Elif Sarıdoğan, Banu Aydın, Hülya Cabadak, Mehmet Zafer Gören. Clin Psychopharmacol Neurosci 2020;18:219-30. https://doi.org/10.9758/cpn.2020.18.2.219

6 May 2008 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
Sezer GorenSezer Goren
Sezer Goren
AKAdem Karahoca
Adem Karahoca
FOFiliz Y. Onat
Filiz Y. Onat
MGMehmet Zafer Goren
Mehmet Zafer Goren

8 June 2014 in Journal of Radiation Research
Verified
Journal Article
Open access
PDF file
HÖHazan Özyurt
Hazan Özyurt
AÖA. Sevgi Özden
A. Sevgi Özden
OCOzge Cevik
Ozge Cevik
ZÖZerrin Özgen
Zerrin Özgen
SÇSelin ÇadIrcI
Selin ÇadIrcI
GŞGöksel Şener
Göksel Şener
It has been previously shown that acetylcholine (ACh) may affect pro-inflammatory and anti-inflammatory cytokines. The role of the cholinergic system in radiation-induced inflammatory responses and tissue damage remains unclear. Therefore, the present study was designed to determine the radio-protective properties of the cholinergic system in the ileum and the liver of rats. Rats were exposed to 8-Gy single-fraction whole-abdominal irradiation and were then decapitated at either 36 h or 10 d post-irradiation. The rats were treated either with intraperitoneal physiological saline (1 ml/kg), physostigmine (80 µg/kg) or atropine (50 μg/kg) twice daily for 36 h or 10 d. Cardiac blood samples and liver and ileal tissues were obtained in which TNF-α, IL-1β and IL-10 levels were assayed using ELISA. In the liver and ileal homogenates, caspase-3 immunoblots were performed and myeloperoxidase (MPO) activity was analyzed. Plasma levels of IL-1β and TNF-α increased significantly following radiation (P < 0.01 and P < 0.001, respectively) as compared with non-irradiated controls, and physostigmine treatment prevented the increase in the pro-inflammatory cytokines (P < 0.01 and P < 0.001, respectively). Plasma IL-10 levels were not found to be significantly changed following radiation, whereas physostigmine augmented IL-10 levels during the late phase (P< 0.01). In the liver and ileum homogenates, IL-1β and TNF-α levels were also elevated following radiation, and this effect was inhibited by physostigmine treatment but not by atropine. Similarly, physostigmine also reversed the changes in MPO activity and in the caspase-3 levels in the liver and ileum. Histological examination revealed related changes. Physostigmine experiments suggested that ACh has a radio-protective effect not involving the muscarinic receptors.